47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
64.92.Z - Other forms of credit granting
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
73.12.C - Advertising through mass media
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,3 | 0,4 | 0,4 | 18,3 |
EBITDA | 0,3 | 0,4 | 0,4 | 17,5 |
Short time liabilities | 0,7 | 0,7 | 0,8 | 8,9 |
Equity capital | 0,8 | 0,5 | 0,5 | -3,6 |
Operating profit (EBIT) | 0,3 | 0,4 | 0,4 | 18,2 |
Assets | 1,6 | 1,3 | 1,3 | 4,2 |
Net profit (loss) | 0,3 | 0,3 | 0,4 | 18,8 |
Cash | 0,6 | 0,2 | 0,2 | -4,5 |
Net income from sale | 6,3 | 7 | 7,9 | 13,3 |
Liabilities and provisions for liabilities | 0,7 | 0,7 | 0,8 | 9,9 |
Working assets | 1,5 | 1,3 | 1,3 | 4,6 |
Depreciation | 0 | 0 | 0 | -69,2 |
% | % | % | p.p. | |
Profitability of capital | 35,6 | 63,7 | 78,5 | 14,8 |
Equity capital to total assets | 54,2 | 42 | 38,9 | -3,1 |
Gross profit margin | 5,3 | 5,4 | 5,7 | 0,3 |
EBITDA Margin | 5,4 | 5,5 | 5,7 | 0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 41 | 39 | 38 | -1 |
Current financial liquidity indicator | 2.139951229095459 | 1.6886119842529297 | 1.607712745666504 | -0,1 |
Net dept to EBITDA | -1.770871639251709 | -0.42059963941574097 | -0.3417419195175171 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane